Training Objectives. By the end of this session you will be able to: 2. Recognize key principles of harm reduction.

Similar documents
Drug Use, Harm Reduction, and HIP

The Principles of Harm Reduction

Breaking the Cycle Though Harm Reduction. Matt La Rocco, BS, CADC Community Liaison Louisville Metro Syringe Exchange Program

Please mute phone lines

Historical Perspectives

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge

Targeted Outreach & Other Strategies for Increasing HCV Testing

The Principles of Harm Reduction

Advancing Health Equity with Harm Reduction Strategies

Welcome to the Webinar

Working with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m.

Harm Reduction at Lummi Tribal Health Center. Jessica Rienstra RN

As a result of this training, participants will be able to:

ORGANIZATION OF AMERICAN STATES

Note: Staff who work in case management programs should attend the AIDS Institute training, "Addressing Prevention in HIV Case Management.

As a result of this training, participants will be able to:

CPAA Opioid Response Workgroup Meeting

Presenters. Session Objectives. Session Overview. Cluster Investigations in Rural Wisconsin

Albuquerque Health Care for the Homeless (AHCH)

Harm Reduction 10/17/2018. Topics for Today. Working Definition of Harm Reduction

SYRINGE SERVICES PROGRAMS IN INDIANA

Workforce Safety for Syringe Services Programs (SSP)

Protecting and Promoting Health and Equity

Syringe Service Programs: Platforms for Engagement. September 28, 2018 Melissa Green, MASW, LSW Harm Reduction Program Manager Columbus Public Health

who use drugs in order to assist them in reducing harm while in the cycle of addiction

Alabama s Emerging Hepatitis C Epidemic and Vulnerability to an Outbreak of HIV Infection Among Persons Who Inject Drugs

Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next

Local Legislative Approval and Program Certification

Meeting People Where they Are: Hepatitis C, Wound care and Syringe Access. Heather Lusk, MSW

Infectious Disease Control for Persons Who Inject Drugs through a Harm Reduction Approach

Harm Reduction in a Clinical Encounter: Collecting substance use history in a non-judgmental manner

Harm Reduction Approaches:

Harm Reduction. Christopher Shaw, PMHNP Massachusetts General Hospital.

Advocating for Syringe Exchange Programs

Jefferson County Syringe Exchange Program (SEP) Annual Report 2017

NIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse

Syringe Exchange Programs December 2005

The Syndemics of HIV, Hepatitis, and Overdose

Harm Reduction. Christopher Shaw, PMHNP Massachusetts General Hospital.

Oregon s Syndemic: Substance Use, Overdose, STIs, associated conditions and IDU-related infections. Framework and Response Models

Harm Reduction 3/5/2019. Topics for Today. Working Definition of Harm Reduction. Scott Stokes Section Chief, Substance Abuse Services

CitiWide Harm Reduction

Needle and Syringe Programs - 17 October 2013

Prevention Point Philadelphia

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.

Harm Reduction: Blending Principles and Practice

Hospitals Role in Addressing the Opioid Crisis

Syringe Exchange An Intervention that Works to Control the Spread of Hepatitis C and HIV. Health Department

Just Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health

HOUSING FIRST- PERMANENT SUPPORTIVE HOUSING- HARM REDUCTION STRATEGIES

Change Attitudes, Change Actions, and Champion Recovery in Healthcare

HIV & HCV in TN: State of the State

Harm Reduction In our communities, in our hospitals. AARM Conference September 14, 2017 Angela Baird RN, BN

Overview of Evidence for Sterile Syringe Access. Hilary McQuie Western Director Harm Reduction Coalition

Advancing the National HIV/AIDS Strategy: Housing and the HCCI. Housing Summit Los Angeles, CA

Overview of Syringe Exchange Programs. New York City Police Academy November 24, 2004

Questions & Answers. What are the risks associated with consumption drug use?

Interior AIDS Association

PH52. Audit tool for the implementation of. NICE public health guidance 52 Needle and syringe programmes

The impact of economic recession on drug users and drug treatment

Viral Hepatitis in the U.S.: Federal Partner Update

Removing the Stigma from Substance Use Disorder. Joan Duwve, MD, MPH Associate Dean for Practice Richard M. Fairbanks School of Public Health

Philadelphia Dept. of Public Health s Approach to the Viral Hepatitis, HIV, and Opioid Syndemics

Guidelines For Services Providing Injecting Equipment

UNDERSTANDING SYRINGE EXCHANGE IN UTAH. Amelia Prebish, MPH Heather Bush, BS Mindy Vincent, LCSW

The Role of Urgent Care in responding to the opioid Crisis

Hepatitis C in Massachusetts Epidemiology and Public Health Response

HARM REDUCTION IN CANADA LESSONS LEARNED AND REFLECTIONS. Marilou Gagnon, RN, PhD Associate Professor School of Nursing University of Victoria

HIV AND PEOPLE WHO INJECT DRUGS

Update on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018

HARM REDUCTION & TREATMENT. Devin Reaves MSW

The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015

Steve Alsum. The Grand Rapids Red Project (616)

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs

HIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons

Part 1: Introduction & Overview

HIV Prevention Service Provider Survey 2014

End AIDS: The HIV Prevention & Outreach Summit Call for Workshop Submissions

High Impact Prevention for People Who Inject Drugs. June 30, 2015

What s The Point? The unique role of pharmacists in HIV/HCV. prevention efforts BAY AREA AND NORTH COAST AREA APRIL 30, 2016

Successful Prevention Strategies to Address the Opioid Crises

Advocating for Sensible Policies in the Age of HCV Cure

Needle Exchange Programs

Syringe Exchange Programs: Getting Started

PERFORMANCE AND IMAGE ENHANCING DRUGS

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS

HARM REDUCTION LAUREN PREST ADDICTION PSYCHIATRY FELLOW 2018 UNIVERSITY OF UTAH HEALTH, 2018

Marguerite A. Erme, DO, MPH Summit County Public Health November

Care not Corrections SUMMARY REPORT APRIL Relieving the Opioid Crisis in Canada CANADIAN MENTAL HEALTH ASSOCIATION

Addiction and Substance misuse pathways

Amanda Archer, BS, MPH

Victorian Parliamentary Inquiry into the Drugs, Poisons and Controlled Substances Amendment (Pilot Medically Supervised Injecting Centre) Bill 2017

Becoming a harm reduction distribution agency in Toronto - information session

UNAIDS 99.1E (English original, March 1999) This document, presenting a speech given at the United Nations General Assembly Special Session on Drugs,

Take Home Naloxone elearning Module Script

Strategies to Reduce Harm and HIV/AIDS Infection among Drug Using Populations

2018 HEI Case Management and HIV Street Outreach Supervisors Meeting Collaborative Notes from January 29 th, 2018

Syringe Access & Disposal Services in SF

Innovative Ways to Fund Harm Reduction Services New Mexico

Addiction Therapy-2014

Transcription:

Training Objectives By the end of this session you will be able to: 1. Define harm reduction. 2. Recognize key principles of harm reduction. 3. Identify the need for harm reduction, with a PWID focus.

Glossary PWID People Who Inject Drugs PWUD People Who Use Drugs PLWHA People Living with HIV/AIDS SUDs Substance Use Disorders SAS Syringe Access Services SEP Syringe Exchange Program AOD Alcohol & Other Drugs

A set of practical strategies that reduce the negative consequences associated with drug use and other risk behaviors. Fertile ground between chaotic drug use and abstinence In relation to drug use it incorporates a spectrum of strategies including safer use, managed use, abstinence. Harm reduction strategies meet people where they're at (but don t leave them there).

Zinberg, N. E. (1984) Drug, Set, And Setting: The Basis for Controlled Intoxicant Use (New Haven: Yale University Press)

Harm Reduction SU Paradigms Rational Actor Disease Model Biopsychosocial

Continuum of Use

Experimental Use Situation al Use Abuse Severely and Persistentl y Chemically Dependent Social & Ritual Use Binge Use Dependenc e

For Example

Harm reduction does not mean anything goes. Harm reduction does not enable drug use or high risk behaviors. Harm reduction does not condone, endorse, or encourage drug use. Harm reduction does not exclude or dismiss abstinence-based treatment models as viable options.

The Problem Focus on criminalization rather than treatment Traditional drug treatment is not always viable or successful Syndemic of HIV, Hep C, and overdose Continued drug user stigma

Reduce Drug User Stigma Increase Trust and Improve Engagement with Clients Improve Individual and Community Health

Individual Community Institutional

Traditional drug treatment is not always a viable option and not a silver bullet Limited availability. People may not be ready to quit or may never choose to. Other reasons?

PWUD will have other issues and needs High prevalence of other health problems. High prevalence of mental health issues. High prevalence of trauma. Poor social support. Higher levels of homelessness. Higher levels of previous incarceration. Poor relationships with healthcare system.

Although the majority of PWID are white, African-American and Latino PWID are 5X more likely to be diagnosed with AIDS. PWID face stigma in all facets of their lives; institutions focus on criminalization over treatment, prevention, and care. Overdose on the rise overdose from opioids currently ranks #1 in accidental deaths in the U.S. Centers for Disease Control and Prevention. National Vital Statistics System, 2015

Stages of Change Transtheoretical Model of Behavior Change Pre-Contemplation Not considering it Return/Relapse Stop doing it Contemplation Thinking about it Maintenance Staying with it Preparation Planning to do it Action Doing it

PRE-CONTEMPLATION Not Considering It CONTEMPLATION Thinking About It PREPARATION Planning To Do It ACTION Doing It MAINTENANCE Staying With It RETURN/RELAPSE Stop Doing It

What are some risk factors related to a person who injects drugs?

Physical Poor health outcomes Violence OD Psychological Depression Isolation Stigma Social Relationship issues Lack of community Isolation from community Spiritual Isolation Not connecting to life Economic $ to acquire drugs Loss of housing Loss of or trouble finding jobs Legal Discrimination Arrest Incarceration

More To Think About What are possible harms you anticipate in relation to drug use behaviors, and overall wellness? What contributing factors may lead to high-risk behaviors and associated harm? What strategies can people in the scenarios adopt to reduce harms and decrease risk in the moment? Explore the possible whys someone is using certain drugs/alcohol.

4. Principles of Harm Reduction Health and Dignity Participant-Centered Services Participant Involvement Participant Autonomy Sociocultural Factors Pragmatism/Realism 24

(1) Focus on Health and Dignity Establishes quality of individual and community life and well-being as the criteria for successful interventions and policies (rather than strictly abstinence). foto by George Hodan

(2) Participant-Centered Services Non-judgmental and non-coercive provision of services and resources. foto by Maliz Ong

(3) Participant Involvement Ensures people have a real voice in the creation of programs and policies designed to serve them.

(4) Participant Autonomy Affirms people who use drugs themselves as their own primary agents of change. foto by CDC/James Gathany

(5) Sociocultural Factors Recognizes the various social inequalities which affect both people's vulnerability to and capacity for effectively dealing with potential harm. foto by Peter Griffin

(6) Pragmatism and Realism Does not attempt to minimize or ignore the real and tragic harm and danger associated with licit and illicit drug use or other risk behaviors. HRC Hepatitis C Prevention Poster

5. Syringe Access Programs Our Roots in Harm Reduction! Doug Wilson Dave Purchase handing out syringes on his own in Tacoma, Wash., in the late 1980s. New York Times, January 27, 2013

October 2014 IRA starts outreach February 2015 HIV cases in Austin, IN March 2015 State of Emergency Declared April 2015 SAS legislation passed May 2015 Aaron s Law (naloxone) passed Monroe County Hepatitis C emergency, SSP proposal, ISDH approval of IRA to deliver services 32

Syringe Access: Reduction in HIV Incidence Syringe access is the most effective, evidencebased HIV prevention tool for people who inject drugs. Federal agencies for national health such as the CDC, SAMHSA, HRSA, and NIDA conclude the use of sterile syringes prevent the spread of HIV and other blood-borne infectious diseases. PWID have reversed the course of the AIDS epidemic by using sterile syringes and harm reduction practices. 80% decrease in new PWID HIV with SSP/MAT Science-based Literature Review on SEPs in the United States 1996-2008. Joanna Berton Martinez

Reduction in Hep C Transmission Risk Almost 1/3 of PWID (31.8%) report sharing syringes and other equipment in U.S.* Many participants of SAPs are referred to Hep B vaccination series and Hep C treatment. Safer injecting equipment education from an SAP assist PWID who do not have Hep C, to stay that way. Every $1 spent saves $7 Over 700 new chronic HCV reported in Monroe County since 2011 = $63,000,000 SSP's as effective structural-level interventions to reduce population-level infection SSP's are effective at increasing treatment of HIV and HCV infection *HIV-Associated Behaviors among Injecting Drug Users 23 Cities, United States, May 2005 Feb 2006 MMWR 2009

Community inclusion, access point Detox and drug treatment programs (5x more likely with SSP) Medical, dental & mental health services Hep A + B Vaccinations HIV/Hep C services Housing services Safer sex supplies & education Overdose prevention Prevention for non-injectors

IRA Harm Reduction 2017 2567 unique participants who use IV drugs 70% of our participants to other services (750 substance use referrals, 280 HIP referrals, 435 MH, and over 500 HIV/Hep C tests, Distributed 10,456 doses naloxone w/1105 reversals. Trained hundreds of volunteers to look for and dispose of improperly disposed syringes. Open 7 days a week w/various locations at varied times. General services (nursing triage, blankets and jackets, clothing, feminine products, camping gear). Connection! 36

6. Ally and Provider Tips Do say they don t know when they don t know. Do celebrate small wins. Do roll with the punches. Do set limits and boundaries. Do keep their humor. Do learn from their mistakes. Do take care of themselves.

Ally and Provider Tips Avoid becoming a rescuer. Avoid taking it personally. Avoid the assumption they have the same goals as the person using drugs. Avoid trying to do this alone. Avoid manipulating or coercing PUD to change.

Indianarecoveryalliance.org 118 S Rogers St Suite 2 Bloomington, IN 47404 PO Box 394 Bloomington IN 47402 harmreduction.org